Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP624673.RA2YB2Y095UMPSd-rVqt2V7ZHr36RIGCPUJQSD_MNvi48130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP624673.RA2YB2Y095UMPSd-rVqt2V7ZHr36RIGCPUJQSD_MNvi48130_assertion type Assertion NP624673.RA2YB2Y095UMPSd-rVqt2V7ZHr36RIGCPUJQSD_MNvi48130_head.
- NP624673.RA2YB2Y095UMPSd-rVqt2V7ZHr36RIGCPUJQSD_MNvi48130_assertion description "[The relationship between 5-FU and gemcitabine sensitivity and the mRNA levels of human equilibrative nucleoside transporter 1 (hENT1), thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) was investigated using seven types of human pancreatic carcinoma cell line (AsPC1, BxPC3, MiaPaCa-2, PSN1, Panc1, PCI6, and KMP-4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624673.RA2YB2Y095UMPSd-rVqt2V7ZHr36RIGCPUJQSD_MNvi48130_provenance.
- NP624673.RA2YB2Y095UMPSd-rVqt2V7ZHr36RIGCPUJQSD_MNvi48130_assertion evidence source_evidence_literature NP624673.RA2YB2Y095UMPSd-rVqt2V7ZHr36RIGCPUJQSD_MNvi48130_provenance.
- NP624673.RA2YB2Y095UMPSd-rVqt2V7ZHr36RIGCPUJQSD_MNvi48130_assertion SIO_000772 17695509 NP624673.RA2YB2Y095UMPSd-rVqt2V7ZHr36RIGCPUJQSD_MNvi48130_provenance.
- NP624673.RA2YB2Y095UMPSd-rVqt2V7ZHr36RIGCPUJQSD_MNvi48130_assertion wasDerivedFrom befree-2016 NP624673.RA2YB2Y095UMPSd-rVqt2V7ZHr36RIGCPUJQSD_MNvi48130_provenance.
- NP624673.RA2YB2Y095UMPSd-rVqt2V7ZHr36RIGCPUJQSD_MNvi48130_assertion wasGeneratedBy ECO_0000203 NP624673.RA2YB2Y095UMPSd-rVqt2V7ZHr36RIGCPUJQSD_MNvi48130_provenance.